Can a video call replace the Doctor's office for opioid addiction treatment?

NCT ID NCT05339256

Not yet recruiting Disease control Sponsor: New York State Psychiatric Institute Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving buprenorphine (a medication for opioid addiction) through telemedicine works as well as in-person care. Fifty adults with opioid use disorder will be randomly assigned to either remote or in-person treatment. The main goal is to see how long people stay in treatment before dropping out.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: buprenorphine (sublingual)
What this could lead to: If successful, this could show that telemedicine is a safe and effective way to deliver buprenorphine treatment, making it easier for people with opioid use disorder to get help.
What could go wrong: This is a small, early-phase study with only 50 participants, so results may not apply to everyone. Telemedicine may not work as well for those with severe addiction or unstable living situations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER

More trials for these conditions

Other studies related to the condition(s) this trial covers.